PATH Pre-Earnings History Points to a Sharp Rally
Market Chameleon (Wed, 20-Nov 5:15 AM ET)
UiPath (PATH) Receives a Rating Update from a Top Analyst
TipRanks (Tue, 19-Nov 8:47 PM ET)
UiPath Announces Third Quarter Fiscal 2025 Financial Results Conference Call
Business Wire (Thu, 7-Nov 4:10 PM ET)
Deluxe Named UiPath AI25 Award Winner
Business Wire (Thu, 24-Oct 10:00 AM ET)
Omega Healthcare Processes 60 Million Transactions with Enterprise AI and Automation from UiPath
Business Wire (Wed, 23-Oct 5:00 PM ET)
Business Wire (Wed, 23-Oct 2:00 PM ET)
Franaise des Jeux Achieves Significant Efficiency Gains with UiPath's AI-Powered Automation
Business Wire (Wed, 23-Oct 1:00 PM ET)
UiPath Announces 2024 AI25 Award Winners
Business Wire (Wed, 23-Oct 12:00 PM ET)
Business Wire (Tue, 22-Oct 2:00 PM ET)
UiPath Unveils New Vision for the Future: Expanding the Boundaries of AI with Agentic Automation
Business Wire (Tue, 22-Oct 1:00 PM ET)
UiPath offers an end-to-end cross-application enterprise automation platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.
Uipath Class A trades on the NYSE stock market under the symbol PATH.
As of November 22, 2024, PATH stock price climbed to $14.56 with 6,745,368 million shares trading.
PATH has a beta of 2.07, meaning it tends to be more sensitive to market movements. PATH has a correlation of 0.16 to the broad based SPY ETF.
PATH has a market cap of $8.01 billion. This is considered a Mid Cap stock.
Last quarter Uipath Class A reported $316 million in Revenue and $.04 earnings per share. This beat revenue expectation by $13 million and exceeded earnings estimates by $.01.
In the last 3 years, PATH traded as high as $52.65 and as low as $10.37.
The top ETF exchange traded funds that PATH belongs to (by Net Assets): ARKK, VTI, VB, VGT, VXF.
PATH has underperformed the market in the last year with a return of -19.9%, while SPY returned +32.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PATH shares. However, PATH has outperformed the market in the last 3 month and 2 week periods, returning +18.9% and +8.8%, while SPY returned +6.5% and 0.0%, respectively. This indicates PATH has been having a stronger performance recently.
PATH support price is $13.29 and resistance is $14.07 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PATH shares will trade within this expected range on the day.